Universe Pharmaceuticals INC (UPC): Price and Financial Metrics


Universe Pharmaceuticals INC (UPC): $1.76

0.17 (+10.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add UPC to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

UPC Stock Summary

  • UPC has a higher market value than only 10.56% of US stocks; more precisely, its current market capitalization is $34,691,250.
  • With a one year PEG ratio of 0.53, UNIVERSE PHARMACEUTICALS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 4.94% of US stocks.
  • UNIVERSE PHARMACEUTICALS INC's stock had its IPO on March 23, 2021, making it an older stock than merely 6.64% of US equities in our set.
  • Stocks that are quantitatively similar to UPC, based on their financial statements, market capitalization, and price volatility, are CLRO, WAVE, TARO, CMCM, and AVGR.
  • UPC's SEC filings can be seen here. And to visit UNIVERSE PHARMACEUTICALS INC's official web site, go to www.dzrzy.com.

UPC Valuation Summary

  • In comparison to the median Healthcare stock, UPC's price/sales ratio is 65% lower, now standing at 0.7.
  • Over the past 20 months, UPC's price/earnings ratio has gone down 7.6.

Below are key valuation metrics over time for UPC.

Stock Date P/S P/B P/E EV/EBIT
UPC 2022-11-25 0.7 0.5 5.6 3.1
UPC 2022-11-23 0.7 0.5 5.5 3.0
UPC 2022-11-22 0.7 0.5 5.5 3.0
UPC 2022-11-21 0.7 0.5 5.3 2.8
UPC 2022-11-18 0.7 0.5 5.3 2.9
UPC 2022-11-17 0.6 0.5 5.0 2.6

UPC Stock Price Chart Interactive Chart >

Price chart for UPC

UPC Price/Volume Stats

Current price $1.76 52-week high $2.34
Prev. close $1.60 52-week low $0.50
Day low $1.60 Volume 449,000
Day high $1.82 Avg. volume 69,521
50-day MA $1.00 Dividend yield N/A
200-day MA $0.96 Market Cap 38.28M

Universe Pharmaceuticals INC (UPC) Company Bio


Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Jiangxi, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.


UPC Latest News Stream


Event/Time News Detail
Loading, please wait...

UPC Latest Social Stream


Loading social stream, please wait...

View Full UPC Social Stream

Latest UPC News From Around the Web

Below are the latest news stories about UNIVERSE PHARMACEUTICALS INC that investors may wish to consider to help them evaluate UPC as an investment opportunity.

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022

Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2022 ended March 31, 2022.

Yahoo | August 16, 2022

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Ji’an, Jiangxi, China, July 19, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on July 15, 2022, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq List

Yahoo | July 19, 2022

Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Ji’an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agreement”) with Lian-Ou Health Pharmaceutical (Guangzhou) Co., Ltd. (“Lian-Ou Health”), a high-tech company focusing on pharmaceuticals, technology, operation, sales, and services, to develop the Company’s digital marketing and expand its

Yahoo | March 30, 2022

Universe Pharmaceuticals INC Authorized as The International Branch of National Engineering Technology Research Center

Ji’an, Jiangxi, China, March 22, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company has been authorized as an International Branch (the “Branch”) of the National Engineering Technology Research Center for Modernization of Traditional Chinese Medicine (the “Center”), a Chinese medicine industry research center approved by the Ministry of Science and Technology of China. As an aut

Yahoo | March 22, 2022

Universe Pharmaceuticals INC's (NASDAQ:UPC) Earnings Are Not Doing Enough For Some Investors

Universe Pharmaceuticals INC's ( NASDAQ:UPC ) price-to-earnings (or "P/E") ratio of 2.8x might make it look like a...

Yahoo | February 9, 2022

Read More 'UPC' Stories Here

UPC Price Returns

1-mo 62.21%
3-mo 234.66%
6-mo 81.35%
1-year -18.52%
3-year N/A
5-year N/A
YTD 7.65%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6568 seconds.